Methylation status of Wnt5a was weakly associated or not associated with several other clinicopathological characteristics in one population, including: pathological N and M substages, local invasion, patient history of irritable bowel syndrome, and patient history of inflammatory bowel disease (Supplementary Table 1). This evidence concerns the gene WNT5A and inflammatory bowel disease.